IL-17 gene polymorphism is associated with susceptibility to gastric cancer

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10025-10030

  Wang, Nan ^a   Yang, Jingyue ^b   Lu, Jianguo ^a   Qiao, Qing ^a   Bao, Guoqiang ^a   Wu, Tao ^a   He, Xianli ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; IL 17; Singlenucleotidepolymorphisms; Susceptibility

Indexed keywords

INTERLEUKIN 17;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COMPLICATION; DRINKING BEHAVIOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MALE; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH TUMOR;

ADULT; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; STOMACH NEOPLASMS;

EID: 84922393649     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2255-8     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125(3):666-73.
3. Wroblewski LE, Peek Jr RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. ClinMicrobiol Rev. 2010;23(4):713-39.
4. Houghton J,Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005;128:1567-78.
5. Merchant JL. Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology. 2005;129:1079-82.
6. Dong LM, Potter JD,White E, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299: 2423-36.
7. Lakhanpal M, Yadav DS, Devi TR, Singh LC, Singh KJ, Latha SP, et al. Association of interleukin-1β -511 C/T polymorphism with tobacco-associated cancer in northeast India: a study on oral and gastric cancer. Cancer Genet. 2014;207(1-2):1-11.
8. Zhang X, Zheng L, Sun Y, Zhang X. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Tumour Biol. 2014;35(2):1575-80.
9. Sun Z, Cui Y, Jin X, Pei J. Association between IL-4-590C>T polymorphism and gastric cancer risk. Tumour Biol. 2014;35(2): 1517-21.
10. Hnatyszyn A, Wielgus K, Kaczmarek-Rys M, Skrzypczak-Zielinska M, Szalata M, Mikolajczyk-Stecyna J, et al. Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz). 2013;61(6):503-12.
11. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003;14: 155-74.
12. Shibata T, Tahara T, Hirata I, Arisawa T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol. 2009;70:547-51.
13. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485-517.
14. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cellmediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol. 2005;175:3920-6.
15. Ishigame H,Kakuta S,Nagai T, et al. Differential roles of interleukin- 17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108-19.
16. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34:149-62.
17. Arisawa T, Tahara T, Shiroeda H, et al. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum Immunol. 2012;73:747-52.
18. Rafiei A, Hosseini V, Janbabai G, et al. Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J Gastroenterol. 2013;19:5693-9.
19. Qinghai Z, Yanying W, Yunfang C, Xukui Z, Xiaoqiao Z. Effect of interleukin-17Aand interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene. 2014;537(2): 328-32.
20. Chechlinska M, Kowalewska M, Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer. 2010;10:2-3.
21. Lee DY, Hong SW, Chang YG, LeeWY, Lee B. Clinical significance of preoperative inflammatory parameters in gastric cancer patients. J Gastric Cancer. 2013;13:111-6.
22. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-41.
23. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65-70.
24. Costa VS, Mattana TC, da Silva ME. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res Clin Pract. 2010;88:222-6.
25. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60-9.
26. Chen JM, Ferec C, Cooper DN. A systematic analysis of diseaseassociated variants in the 39 regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 39 UTR variants. Hum Genet. 2006;120:301-33.
27. Wu X, Zeng Z, Chen B, et al. Association between polymorphisms in interleukin-17Aand interleukin-17F genes and risks of gastric cancer. Int J Cancer. 2010;127:86-92.